Related references
Note: Only part of the references are listed.Dementia in China: epidemiology, clinical management, and research advances
Longfei Jia et al.
LANCET NEUROLOGY (2020)
Usage and adherence of antidementia drugs in a memory clinic cohort in Chongqing, Southwest China
Xingyan Yu et al.
PSYCHOGERIATRICS (2020)
Trends of antidementia drugs use in outpatients with Alzheimer's disease in six major cities of China: 2012-2017
Lingyan Yu et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2019)
Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia
R. E. Brimelow et al.
INTERNATIONAL PSYCHOGERIATRICS (2019)
A cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: issues of concern
Mitchell McMaster et al.
INTERNATIONAL PSYCHOGERIATRICS (2018)
Prevalence of dementia in mainland China, Hong Kong and Taiwan: an updated systematic review and meta-analysis
Yu-Tzu Wu et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review
Jiri Masopust et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Psychotropic drug use and mortality in old people with dementia: investigating sex differences
Jon Brannstrom et al.
BMC PHARMACOLOGY & TOXICOLOGY (2017)
Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors
Anne Sverdrup Efjestad et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2017)
Delayed help seeking behavior in dementia care: preliminary findings from the Clinical Pathway for Alzheimer's Disease in China (CPAD) study
Mei Zhao et al.
INTERNATIONAL PSYCHOGERIATRICS (2016)
Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China
Jianping Jia et al.
ALZHEIMERS & DEMENTIA (2016)
Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing
Kieran Anthony Walsh et al.
INTERNATIONAL PSYCHOGERIATRICS (2016)
Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study
Daniela Koller et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments
Fleur Harrison et al.
CURRENT PSYCHIATRY REPORTS (2016)
Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011
Christine Gulla et al.
BMC GERIATRICS (2016)
Concomitant use of psychotropics and donepezil in Japanese patients with dementia: Pooled postmarketing surveillance data analysis
Kasumi Daidoji et al.
JOURNAL OF CLINICAL GERONTOLOGY & GERIATRICS (2016)
Pharmacotherapy of dementia in Germany: Results from a nationwide claims database
Jens Bohlken et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
Hui-Fu Wang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Memantine for the treatment of frontotemporal dementia: a meta-analysis
Taro Kishi et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)
Factors Related to Psychotropic Drug Prescription for Neuropsychiatric Symptoms in Nursing Home Residents With Dementia
Claudia H. W. Smeets et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2014)
Differences in Drug Therapy between Dementia Disorders in the Swedish Dementia Registry: A Nationwide Study of over 7,000 Patients
Kristina Johnell et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)
Pharmacologic Treatment of Apathy in Dementia
Karen Berman et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Frontotemporal Lobar Degeneration Epidemiology, Pathology, Diagnosis and Management
Rachel E. Seltman et al.
CNS DRUGS (2012)
New Insights Dose-Response Relationship Between Psychotropic Drugs and Falls: A Study in Nursing Home Residents With Dementia
Carolyn S. Sterke et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians
Elke Jeschke et al.
BMC NEUROLOGY (2011)
Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians' prescription behavior
Sytse U. Zuidema et al.
INTERNATIONAL PSYCHOGERIATRICS (2011)
Prescribing pattern of psychotropic drugs in nursing home residents with dementia
R. B. Wetzels et al.
INTERNATIONAL PSYCHOGERIATRICS (2011)
Concomitant use of anti-dementia drugs with psychotropic drugs in Norway-a population-based study
Ellen Melbye Langballe et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine
Joanne Rodda et al.
INTERNATIONAL PSYCHOGERIATRICS (2009)
The uniform data set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer disease centers
John C. Morris et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Efficacy and tolerability of donepezil in vascular dementia -: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial
S Black et al.
STROKE (2003)
Efficacy and safety of memantine in patients with mild to moderate vascular dementia -: A randomized, placebo-controlled trial (MMM 300)
JM Orgogozo et al.
STROKE (2002)
A 5-month, randomized, placebo-controlled trial of galantamine in AD
PN Tariot et al.
NEUROLOGY (2000)
Share Paper
